Levecetra 30 GM/1 BOT Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

levecetra 30 gm/1 bot

المتقدمة لصناعة المستحضرات الصيدلانية - almotakademah for pharmaceutical preperations - levetiracetam 30 gm/1 bot - 30 gm/1 bot

ORS New 0.30 gm, 0.52 gm, 2.7 gm, 0.58 gm Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

ors new 0.30 gm, 0.52 gm, 2.7 gm, 0.58 gm

مستودع ادوية رضا جردانة - reda jardaneh drug store - potassium chloride 0.30 gm, sodium chloride 0.52 gm, anhydrous dextrose 2.7 gm, tri sodium citrate dihydrate 0.58 gm - 0.30 gm, 0.52 gm, 2.7 gm, 0.58 gm

BONETO OINTMENT 30 GM Combination United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

boneto ointment 30 gm combination

arabian ethicals co. jordan - 30 gm tube in white cartoon pack - ointment - combination - skin-wound management

ACTIVE FE- .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine hydrochloride, riboflavin, United States - English - NLM (National Library of Medicine)

active fe- .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine hydrochloride, riboflavin,

gm pharmaceuticals, inc. - .beta.-carotene (unii: 01yae03m7j) (.beta.-carotene - unii:01yae03m7j), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8r - .beta.-carotene 2100 [iu] - active fe™ is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias.1 active fe™ is contraindicated in patients with a known hypersensitivity to any of the components of this product. hemolytic anemia, hemochromatosis and hemosiderosis are contraindications to iron therapy.

MEZO 30 GM CRM GM India - English - Central Drugs Standard Control Organization

mezo 30 gm crm gm

agio ph. - mometasone - crm gm - 0.1 (methylparaben ip 0.02% w/w,proplylparaben ip 0.02;% w/w) - 30 gm

Eskanex 30% Powder (Vet) Bangladesh - English - DGDA (Directorate General of Drug Administration)

eskanex 30% powder (vet)

eskayef pharmaceuticals ltd., narayanganj - levamisole - powder - 30 gm/100 gm

Eskanex 30% Powder Bangladesh - English - DGDA (Directorate General of Drug Administration)

eskanex 30% powder

eskayef pharmaceuticals ltd., tongi,gazipur - levamisole - powder - 30 gm/100 gm

Humulin 30/70 New Zealand - English - Medsafe (Medicines Safety Authority)

humulin 30/70

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus

TEXACLEAR- allergy relief tablet United States - English - NLM (National Library of Medicine)

texaclear- allergy relief tablet

gm pharmaceuticals, inc - chlophedianol hydrochloride (unii: 69qq58998y) (chlophedianol - unii:42c50p12ap), pyrilamine maleate (unii: r35d29l3za) (pyrilamine - unii:hpe317o9tl) - chlophedianol hydrochloride 25 mg - cough suppressant antihistamine - temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: runny nose itchy, watery eyes itching of the nose or throat sneezing cough due to minor throat and bronchial irritation - runny nose - itchy, watery eyes - itching of the nose or throat - sneezing - cough due to minor throat and bronchial irritation

VANATOL S- butalbital, acetaminophen and caffeine syrup United States - English - NLM (National Library of Medicine)

vanatol s- butalbital, acetaminophen and caffeine syrup

gm pharmaceuticals - butalbital (unii: khs0az4jvk) (butalbital - unii:khs0az4jvk), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - butalbital 50 mg in 15 ml - vanatol ® s is indicated for the relief of the symptom complex of tension (or muscle contraction) headache. evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. caution in this regard is required because butalbital is habit-forming and potentially abusable. this product is contraindicated under the following conditions: - hypersensitivity or intolerance to any component of this product. - patients with porphyria. butalbital: babiturates may be habit forming: tolerance, psychological dependence, and physical dependence may occur especially following prolonged use of high doses of barbiturates. the average daily dose for the barbiturate addict is usually about 1500 mg. as tolerance to barbiturates develops, the amount needed to maintain the same level of intoxication increases; tolerance to a fatal dosage, however, does not increase more than two-fold. as this occurs, the margin between an into